Concepedia

Amy Sims

AS

Statistics

Publications

66

Citations

18.6K

H-Index

43

Active since

1998

Affiliations

University of North Carolina at Chapel Hill(Current)

Pacific Northwest National Laboratory

Vanderbilt University Medical Center

University of Wisconsin–Madison

Vanderbilt University

Amy Sims is an author at University of North Carolina at Chapel Hill specializing in life sciences, virology, and molecular virology.

ORCID

Publications per year

1998–2024

66

Publications

66

Sharing and community curation of mass spectrometry data with Global Natural Products Social Molecular Networking

Mingxun Wang, Jeremy Carver, Vanessa V. Phelan et al. · Nature Biotechnology · 2016 · 4.6K citations · Full text

, , +14

Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV

Timothy P. Sheahan, Amy Sims, Sarah R. Leist et al. · Nature Communications · 2020 · 1.8K citations · Full text

, , +12

Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses

Timothy P. Sheahan, Amy Sims, Rachel L. Graham et al. · Science Translational Medicine · 2017 · 1.6K citations · Full text

, , +14

Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease

Maria L. Agostini, Erica L. Andres, Amy Sims et al. · mBio · 2018 · 1.5K citations · Full text

, , +16

An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice

Timothy P. Sheahan, Amy Sims, Shuntai Zhou et al. · Science Translational Medicine · 2020 · 1.2K citations · Full text

, , +17

1–5 of 66